miRNA-22 inhibits VSMCs apoptosis during AD vascular remodeling by targeting p38 mitogen-activated protein kinase α(p38MAPKα) [44] and miR-146a-5p enhances VSMCs proliferation and migration by targeting SMAD4 [45]. The gene discussed is SMAD4; the disease is Alzheimer disease.